Header Logo

Connection

Amanda Krause to Haplotypes

This is a "connection" page, showing publications Amanda Krause has written about Haplotypes.
Connection Strength

0,612
  1. A Comprehensive Haplotype-Targeting Strategy for Allele-Specific HTT Suppression in Huntington Disease. Am J Hum Genet. 2019 12 05; 105(6):1112-1125.
    View in: PubMed
    Score: 0,158
  2. Junctophilin 3 (JPH3) expansion mutations causing Huntington disease like 2 (HDL2) are common in South African patients with African ancestry and a Huntington disease phenotype. Am J Med Genet B Neuropsychiatr Genet. 2015 Oct; 168(7):573-85.
    View in: PubMed
    Score: 0,117
  3. Genetic factors influencing inhibitor development in a cohort of South African haemophilia A patients. Haemophilia. 2014 Sep; 20(5):687-92.
    View in: PubMed
    Score: 0,109
  4. Huntington disease in the South African population occurs on diverse and ethnically distinct genetic haplotypes. Eur J Hum Genet. 2013 Oct; 21(10):1120-7.
    View in: PubMed
    Score: 0,100
  5. Multiple TP53 p.R337H haplotypes and implications for tumor susceptibility. HGG Adv. 2024 Jan 11; 5(1):100244.
    View in: PubMed
    Score: 0,052
  6. The molecular epidemiology of Huntington disease is related to intermediate allele frequency and haplotype in the general population. Am J Med Genet B Neuropsychiatr Genet. 2018 04; 177(3):346-357.
    View in: PubMed
    Score: 0,035
  7. Clinical and genetic characterization of a founder PKHD1 mutation in Afrikaners with ARPKD. Pediatr Nephrol. 2015 Feb; 30(2):273-9.
    View in: PubMed
    Score: 0,028
  8. A common Fanconi anemia mutation in black populations of sub-Saharan Africa. Blood. 2005 May 01; 105(9):3542-4.
    View in: PubMed
    Score: 0,014
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.